Clinical Trials · NCT01791465
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Vanderbilt University
- Enrollment
- 6
- Start date
- Mar 2013
- Locations
- 1 site, United States
- Primary endpoint
- Serum Highly-sensitive C-reactive Protein (hsCRP) Levels at Baseline and 16 Weeks